Your Health and Safety is our Priority. Learn more about our COVID-19 Safety Protocols
Everyone is talking about the newest treatment for reducing fat under the chin or “double chin” but does it deserve all the hype? Get the facts on Kybella here.
A: Kybella (deoxycholic acid) works by permanently reducing the fat cells in the treatment area. However, a large increase in weight can cause the area to appear fuller again. As the aging process continues, there may be looseness and sagging of the skin in the chin and neck areas and there are other procedures to address these issues.
A: Yes, extensive clinical trials have shown that Kybella successfully reduces excessive submental fat. In the trials, patients received up to 6 treatments but many saw improvements with fewer treatments. Kybella is most suitable for people with isolated fat pockets under the chin without excessive loose skin or sagging.
A: During your consultation, your physician will discuss your expectations and whether this is the ideal procedure for you. If you decide to proceed, the physician will first clean and mark out the treatment site then numb the area using lidocaine injections. The medication will then be injected in a grid pattern evenly over the chin. The entire procedure should take less than 30 minutes. Side effects including swelling, discomfort, numbness, redness and bruising should resolve within a week.
A: Swelling in the treated area can give a “bullfrog appearance” for up to a week and may vary from patient to patient. This does not limit any daily activities but some patients may not like the temporary fuller appearance of the chin. Side effects from subsequent treatments are usually milder. Other risks including bruising and redness are typically minimal.
Overall, the results so far have been excellent with Kybella injections. Our board certified doctors are trained on how to administer Kybella and can determine if it is the right treatment for your desired cosmetic outcome. Call us at 1-855-793-2868 to schedule a consultation today.